Researchers at Johns Hopkins have determined that seniors are at the greatest risk of methicillin-resistant Staphylococcus aureus (MRSA) infections in the winter months.
Healthcare-associated MRSA infections most commonly affect people 65 years and older. The researchers determined that these infections typically peak in February or March. They theorize that this is tied to antibiotic use during the winter flu season. Healthcare-associated MRSA strains show a corresponding resistance to the antibiotics that are commonly prescribed during the flu season.
To learn more, click here.
Showing posts with label MRSA. Show all posts
Showing posts with label MRSA. Show all posts
Tuesday, March 5, 2013
Thursday, February 14, 2013
New Oral Antibiotic Shows Promise for Treating MRSA-Related Skin Infections
According to a new study published in the Journal of the American Medical Association, a new oral antibiotic may effectively treat MRSA-related skin infections more quickly than the only oral drug currently approved for treating these infections.
The new oral antibiotic is tedizolid phosphate, which was determined to be "clinically noninferior" to linezolid, the only drug currently approved for treating skin structure infections, or SSIs, caused by MRSA. These infections can be deadly.
The researchers also noted that there have been outbreaks of linezolid-resistant strains of MRSA.
To learn more, click here.
The new oral antibiotic is tedizolid phosphate, which was determined to be "clinically noninferior" to linezolid, the only drug currently approved for treating skin structure infections, or SSIs, caused by MRSA. These infections can be deadly.
The researchers also noted that there have been outbreaks of linezolid-resistant strains of MRSA.
To learn more, click here.
Subscribe to:
Posts (Atom)
Since 1968, Professional Medical has been a dedicated supplier to the long-term care industry. Our education, resources and products are designed to make improving care easier!
Posts
